Express check-up
This Bengaluru-based start-up can diagnose drug-resistance in tuberculosis patients in just few hours
Debangana Ghosh - September 30, 2019
Testing demand
Dr Lal PathLabs CEO Om Manchanda sells stake as the stock gains over 50% over the past one year
Prathamesh Mulye - March 11, 2020
Om Manchanda
A week-long hiking trip has become an annual ritual for the CEO of Dr Lal Pathlabs, to keep him spirited for the rest of the year
January 10, 2020
‘Path’ breaker
Dr Lal PathLabs wisely planned its expansion, optimising cost along the way, and doubled its revenue and profit over five years
Himanshu Kakkar - May 16, 2019
Saurabh Mukherjea
Dr Lal Pathlabs stands out for its unique hub-and-spoke business model and strong return ratios
April 15, 2019
Living The High Life
Dr Lal PathLabs’s Om Prakash Manchanda has an undying love for trekking, a passion he wishes to pursue for a lifetime
Tanya Baisoya - October 18, 2018
Living the High Life
Dr Lal PathLabs’s Om Prakash Manchanda has an undying love for trekking, a passion he wishes to pursue for a lifetime
Tanya Baisoya - October 20, 2018
The SRL Listing Is All Squeezed Out
The run-up in the stock implies all the exuberance is in the price
Jitendra Kumar Gupta - August 25, 2016
Public party - Part 2
In the second part, a look at Narayana Hrudayalaya and diagnostic player Thyrocare
Jash Kriplani - August 08, 2016
